|
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney diseaseGobe, GC, Vesey, DA, Bennett, NC and Johnson, DW (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x |
|
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney diseaseBennett, N., Colditz, P., Gobe, G. C., Johnson, D., Patel, J. and Vesey, D. A. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney disease. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. HOBOKEN: Australian and New Zealand Society of Nephrology (ANZSN). doi: 10.1111/j.1440-1797.2008.001013.x |
|
2007 Journal Article Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathwayLi, Jun, Vesey, David A., Johnson, David W. and Gobe, Glenda C. (2007). Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway. Cancer Biology Therapy, 6 (12), 1944-1950. doi: 10.4161/cbt.6.12.4975 |
|
2007 Journal Article Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activationVesey, David A., Kruger, Wade A., Poronnik, Philip, Gobe, Glenda C. and Johnson, David W. (2007). Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation. American Journal of Physiology: Renal Physiology, 293 (5), F1441-F1449. doi: 10.1152/ajprenal.00088.2007 |
|
2007 Journal Article Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levelsCheung, Catherine W., Taylor, Paul J., Kirkpatrick, Carl M.J., Vesey, David A., Gobe, Glenda C., Winterford, Clay, Nicol, David L. and Johnson, David W. (2007). Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levels. BJU International, 100 (2), 438-444. doi: 10.1111/j.1464-410X.2007.07012.x |
|
2007 Journal Article Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapiesYang, Tao, Vesey, David A., Johnson, David W., Wei, Ming Q. and Gobe, Glenda C. (2007). Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies. Translational Research, 150 (1), 40-50. doi: 10.1016/j.trsl.2007.01.006 |
|
2007 Journal Article Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)Qi, Weier, Johnson, David W., Vesey, David A., Pollock, Carol A. and Chen, Xinming (2007). Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research). Nephrology, 12 (2), 155-159. doi: 10.1111/j.1440-1797.2007.00779.x |
|
2007 Journal Article Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3Cheung, Catherine W., Vesey, David A., Nicol, David L. and Johnson, David W. (2007). Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3. BJU International, 99 (2), 454-460. doi: 10.1111/j.1464-410X.2007.06571.x |
|
2007 Journal Article Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidneyVesey, David A., Hooper, John D., Gobe, Glenda C. and Johnson, David W. (2007). Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney. Nephrology, 12 (1), 36-43. doi: 10.1111/j.1440-1797.2006.00746.x |
|
2007 Conference Publication Erythropoietin: Novel applications beyond anaemia treatmentVesey, D. A., Gobe, G. C. and Johnson, D. W. (2007). Erythropoietin: Novel applications beyond anaemia treatment. 2nd International Conference of Naresuan University, Phitsanulok, Thailand, 27-28 July, 2007. |
|
2007 Conference Publication The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapyLi, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. 32nd Lorne Conference on Protein Structure and Function, Lorne, Victoria, Australia, 4-8 February 2007. Lorne, Vic., Australia: |
|
2007 Conference Publication The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapyLi, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. World Congress of Nephrology, Rio De Janeiro, Brazil, 21-25 April , 2007. International Society of Nephrology (ISN). |
|
2006 Journal Article Novel renoprotective actions of erythropoietin: New uses for an old hormoneJohnson, David W., Forman, Colin and Vesey, David A. (2006). Novel renoprotective actions of erythropoietin: New uses for an old hormone. Nephrology, 11 (4), 306-312. doi: 10.1111/j.1440-1797.2006.00585.x |
|
2006 Journal Article Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failureJohnson, D. W., Pat, B., Vesey, D. A., Guan, Z., Endre, Z. and Gobe, G. C. (2006). Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney International, 69 (10), 1806-1813. doi: 10.1038/sj.ki.5000356 |
|
2006 Conference Publication PKC regulation of the cyclin dependent kinase inhibitor p21 in normal kidney versus kidney cancer cellsLi, Jun, Vesey, David and Gobe, Glenda (2006). PKC regulation of the cyclin dependent kinase inhibitor p21 in normal kidney versus kidney cancer cells. American Society of Nephrology Renal Research Week, San Diego, USA, 2006. ASN. |
|
2006 Conference Publication Resistance to cancer treatments in renal cell carcinomas: Discovering novel apoptotic pathwaysRajandram, R ., Pat, B., Li, J., Percy, C. J., Vesey, D., Johnson, D. W. and Gobe, G. C. (2006). Resistance to cancer treatments in renal cell carcinomas: Discovering novel apoptotic pathways. Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Melbourne, Australia, 14-18 August 2006. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2006.00656.x |
|
2006 Conference Publication PAR-2 Is expressed by human proximal tubule cells and mediates pro-inflammatory and proliferative responsesGobe, G. C., Johnson, D. W., Kruger, W., Poronnik, P. and Vesey, D. A. (2006). PAR-2 Is expressed by human proximal tubule cells and mediates pro-inflammatory and proliferative responses. Renal Week 2006: American Society of Nephrology Annual Meeting, San Diego, California, U.S., 14 - 19 November, 2006. American Society of Nephrology. |
|
2006 Conference Publication PKC regulation of the cyclin dependent kinase (cdk) inhibitor p21 in normal kidney versus kidney cancer cellsLi, J., Vesey, D. and Gobe, G. (2006). PKC regulation of the cyclin dependent kinase (cdk) inhibitor p21 in normal kidney versus kidney cancer cells. Australia and New Zealand Society of Nephrology and Renal Society of Australasia Annual Scientific Conference, Melbourne, Australia, 14–19 August 2006. |
|
2006 Conference Publication Protective effect of Angelica sinensis on renal vascular endothelial cell damage induced by oxidative stressYamada, M., Vesey, D., Johnson, D. W. and Gobe, G. (2006). Protective effect of Angelica sinensis on renal vascular endothelial cell damage induced by oxidative stress. ANZSN 2006: 42nd Australia and New Zealand Society of Nephrology and Renal Society of Australasia Annual Scientific Conference, Melbourne, Australia, 14-19 August 2006. Carlton, Vic., Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2006.00656.x |
|
2005 Journal Article Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cellsVesey, David A., Cheung, Catherine W., Kruger, Wade A., Poronnik, Philip, Gobe, Glenda and Johnson, David W. (2005). Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells. Kidney International, 67 (4), 1315-1329. doi: 10.1111/j.1523-1755.2005.00209.x |
